Chinese proprietary herbal medicine listed in 'China national essential drug list' for common cold: a systematic literature review.

<h4>Objective</h4>Chinese proprietary herbal medicines (CPHMs) have long history in China for the treatment of common cold, and lots of them have been listed in the 'China national essential drug list' by the Chinese Ministry of Health. The aim of this review is to provide a we...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wei Chen, George Lewith, Li-qiong Wang, Jun Ren, Wen-jing Xiong, Fang Lu, Jian-ping Liu
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2014
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/a47eecb907ac447ba739251285b995de
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a47eecb907ac447ba739251285b995de
record_format	dspace
spelling	oai:doaj.org-article:a47eecb907ac447ba739251285b995de2021-11-25T05:55:58ZChinese proprietary herbal medicine listed in 'China national essential drug list' for common cold: a systematic literature review.1932-620310.1371/journal.pone.0110560https://doaj.org/article/a47eecb907ac447ba739251285b995de2014-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0110560https://doaj.org/toc/1932-6203<h4>Objective</h4>Chinese proprietary herbal medicines (CPHMs) have long history in China for the treatment of common cold, and lots of them have been listed in the 'China national essential drug list' by the Chinese Ministry of Health. The aim of this review is to provide a well-round clinical evidence assessment on the potential benefits and harms of CPHMs for common cold based on a systematic literature search to justify their clinical use and recommendation.<h4>Methods</h4>We searched CENTRAL, MEDLINE, EMBASE, SinoMed, CNKI, VIP, China Important Conference Papers Database, China Dissertation Database, and online clinical trial registry websites from their inception to 31 March 2013 for clinical studies of CPHMs listed in the 'China national essential drug list' for common cold. There was no restriction on study design.<h4>Results</h4>A total of 33 CPHMs were listed in 'China national essential drug list 2012' for the treatment of common cold but only 7 had supportive clinical evidences. A total of 6 randomised controlled trials (RCTs) and 7 case series (CSs) were included; no other study design was identified. All studies were conducted in China and published in Chinese between 1995 and 2012. All included studies had poor study design and methodological quality, and were graded as very low quality.<h4>Conclusions</h4>The use of CPHMs for common cold is not supported by robust evidence. Further rigorous well designed placebo-controlled, randomized trials are needed to substantiate the clinical claims made for CPHMs.Wei ChenGeorge LewithLi-qiong WangJun RenWen-jing XiongFang LuJian-ping LiuPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 10, p e110560 (2014)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Wei Chen George Lewith Li-qiong Wang Jun Ren Wen-jing Xiong Fang Lu Jian-ping Liu Chinese proprietary herbal medicine listed in 'China national essential drug list' for common cold: a systematic literature review.
description	<h4>Objective</h4>Chinese proprietary herbal medicines (CPHMs) have long history in China for the treatment of common cold, and lots of them have been listed in the 'China national essential drug list' by the Chinese Ministry of Health. The aim of this review is to provide a well-round clinical evidence assessment on the potential benefits and harms of CPHMs for common cold based on a systematic literature search to justify their clinical use and recommendation.<h4>Methods</h4>We searched CENTRAL, MEDLINE, EMBASE, SinoMed, CNKI, VIP, China Important Conference Papers Database, China Dissertation Database, and online clinical trial registry websites from their inception to 31 March 2013 for clinical studies of CPHMs listed in the 'China national essential drug list' for common cold. There was no restriction on study design.<h4>Results</h4>A total of 33 CPHMs were listed in 'China national essential drug list 2012' for the treatment of common cold but only 7 had supportive clinical evidences. A total of 6 randomised controlled trials (RCTs) and 7 case series (CSs) were included; no other study design was identified. All studies were conducted in China and published in Chinese between 1995 and 2012. All included studies had poor study design and methodological quality, and were graded as very low quality.<h4>Conclusions</h4>The use of CPHMs for common cold is not supported by robust evidence. Further rigorous well designed placebo-controlled, randomized trials are needed to substantiate the clinical claims made for CPHMs.
format	article
author	Wei Chen George Lewith Li-qiong Wang Jun Ren Wen-jing Xiong Fang Lu Jian-ping Liu
author_facet	Wei Chen George Lewith Li-qiong Wang Jun Ren Wen-jing Xiong Fang Lu Jian-ping Liu
author_sort	Wei Chen
title	Chinese proprietary herbal medicine listed in 'China national essential drug list' for common cold: a systematic literature review.
title_short	Chinese proprietary herbal medicine listed in 'China national essential drug list' for common cold: a systematic literature review.
title_full	Chinese proprietary herbal medicine listed in 'China national essential drug list' for common cold: a systematic literature review.
title_fullStr	Chinese proprietary herbal medicine listed in 'China national essential drug list' for common cold: a systematic literature review.
title_full_unstemmed	Chinese proprietary herbal medicine listed in 'China national essential drug list' for common cold: a systematic literature review.
title_sort	chinese proprietary herbal medicine listed in 'china national essential drug list' for common cold: a systematic literature review.
publisher	Public Library of Science (PLoS)
publishDate	2014
url	https://doaj.org/article/a47eecb907ac447ba739251285b995de
work_keys_str_mv	AT weichen chineseproprietaryherbalmedicinelistedinchinanationalessentialdruglistforcommoncoldasystematicliteraturereview AT georgelewith chineseproprietaryherbalmedicinelistedinchinanationalessentialdruglistforcommoncoldasystematicliteraturereview AT liqiongwang chineseproprietaryherbalmedicinelistedinchinanationalessentialdruglistforcommoncoldasystematicliteraturereview AT junren chineseproprietaryherbalmedicinelistedinchinanationalessentialdruglistforcommoncoldasystematicliteraturereview AT wenjingxiong chineseproprietaryherbalmedicinelistedinchinanationalessentialdruglistforcommoncoldasystematicliteraturereview AT fanglu chineseproprietaryherbalmedicinelistedinchinanationalessentialdruglistforcommoncoldasystematicliteraturereview AT jianpingliu chineseproprietaryherbalmedicinelistedinchinanationalessentialdruglistforcommoncoldasystematicliteraturereview
_version_	1718414357937782784

Chinese proprietary herbal medicine listed in 'China national essential drug list' for common cold: a systematic literature review.

Ejemplares similares